Heart Rate, Cholesterol, and Weight Shifts Vary Widely Across Antidepressant Classes
December 18, 2025
Antidepressants remain among the most prescribed psychotropics worl...
Read More
Cannabidiol Fails to Protect Against Cannabis-Induced Symptoms in Schizophrenia
December 14, 2025
A new study examined whether cannabidiol could mitigate the acute a...
Read More
Patterns of Cannabis and Alcohol Use for Sleep Initiation in Young Adults
December 12, 2025
Sleep difficulties are widespread in young adults, with some indivi...
Read More
Starting Benzodiazepines, Antipsychotics in Hospice with Dementia Linked to Increased Mortality
December 10, 2025
The Medicare hospice benefit was originally designed to care for ca...
Read More
Relapse Criteria in Schizophrenia
December 2, 2025
Relapse prevention is critical in long-term schizophrenia managemen...
Read More
Novel Benzodiazepines Linked to More Severe Opioid Overdoses
November 23, 2025
The combination of opioids and benzodiazepines poses a growing chal...
Read More
Brief Cognitive Behavioral Therapy Shows Promise for Suicide Prevention in Military Populations
November 17, 2025
Suicide attempts among military personnel are notably higher than i...
Read More
Young Investigator Poster Awards
November 7, 2025
Presented below are the winners of the 2025 NEI Fall Congress Young...
Read More
FDA Approves Lumateperone as Adjunctive Treatment for Major Depressive Disorder
November 6, 2025
The FDA has approved lumateperone as an adjunctive therapy with an...
Read More
Child and Adolescent Psychiatry Academy
November 5, 2025
The 2025 NEI Child and Adolescent Psychiatry Academy presented a se...
Read More
GLP-1 Receptor Agonists for the Treatment of Opioid Use Disorders
October 14, 2025
Opioid Use Disorder (OUD) remains a major public health crisis, wit...
Read More
Lurasidone Efficacious for Depression Across Psychiatric Diagnoses
October 10, 2025
Depressive symptoms are a key driver of morbidity across multiple p...
Read More